Back

ERASe - Ertugliflozin to Reduce Arrhythmic burden in ICD/CRT patientS

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Clinical and experimental arrhythmia treatments Antiarrhythmic Drug Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Daniel Scherr

Medical University of Graz, Graz (Austria)

8 More presentations in this session

Presentation thumbnail
Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm
Doctor A. Morena (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes
Doctor P. D'Ambrosio (Fitzroy, AU)
Abstract Slides Video
Presentation thumbnail
Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin
Doctor O. Al-assaf (Dubai, AE)
Abstract Slides Video
Presentation thumbnail
Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure - a matched case-control study
Doctor S. Ali (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure
Doctor H. Sumiyoshi (Kamogawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical and experimental arrhythmia treatments

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a systematic review
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors in sustained ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators for primary prevention
thumbnail
Congress Presentation
Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac defibrillator

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources